Maria C Denis
Chief Executive Officer
Chief Executive Officer
Biomedcode Hellas SA
Greece
Biography
Dr Denis has a B.Sc. in Microbiology from the University of Massachusetts, USA and a PhD in Immunology from Tufts Medical School, USA focusing on the role of post-transcriptional regulation in IL2 bioactivity. MD has more than fifteen years of research experience in academia and industry with sound expertise in immunology, inflammation, autoimmunity, imaging and pre-clinical drug evaluation. From 2001-2003 MD held a joint postdoctoral fellow position at Harvard Medical School in the laboratories of Drs D. Mathis and C. Benoist (Joslin Diabetes Center) and Dr. R. Weissleder (Massachusetts General Hospital), Boston, USA. Her post-doctoral work resulted in the development of a method of imaging pancreatic inflammation in mouse models of type 1 diabetes, a diagnostic tool that has since been translated to the clinic. Her work was supported by an NIH F32 fellowship and an NRSA training fellowship grant. In 2003 Dr. Denis joined the laboratory of Dr G. Kollias at BSRC Al.Fleming, Vari-Athens, Greece, to study the role of TNF-TNFR2 signaling in the pathogenesis of EAE, work supported by a Marie Curie Incoming International Fellowship. In September 2009, Dr. Denis joined Biomedcode's Scientific Management Team first as Head of Preclinical Services and since March 2010 as Chief Executive Officer.
Research Interest
Immunology, inflammation, autoimmunity, imaging and pre-clinical drug evaluation
